 |
submitted by /u/Bemuzed [link] [comments] |
source https://www.reddit.com/r/Health/comments/ebnkdv/researchers_explore_a_drugfree_idea_to_relieve/
Researchers Explore A Drug-Free Idea To Relieve Chronic Pain
source https://www.reddit.com/r/Health/comments/ebnkdv/researchers_explore_a_drugfree_idea_to_relieve/
Dengue fever finds breeding ground in war-weary Yemen
Dengue fever finds breeding ground in war-weary Yemen
Reuters: Health
Ibrahim Ali al-Jadari's four teenage daughters lie at home on intravenous drips that will soon run out as they, like tens of thousands of other Yemenis, battle a seasonal surge of dengue fever.
Reuters: Health
Ibrahim Ali al-Jadari's four teenage daughters lie at home on intravenous drips that will soon run out as they, like tens of thousands of other Yemenis, battle a seasonal surge of dengue fever.
Gilead's NASH combination treatment fails mid-stage study
Gilead's NASH combination treatment fails mid-stage study
Reuters: Health
Gilead Sciences Inc said on Monday all combinations of its three drugs to treat NASH were unsuccessful in a mid-stage study, the latest failure in a string of trials seeking to develop the first approved treatment for the fatty liver disease. 
Reuters: Health
Gilead Sciences Inc said on Monday all combinations of its three drugs to treat NASH were unsuccessful in a mid-stage study, the latest failure in a string of trials seeking to develop the first approved treatment for the fatty liver disease.
Axsome shares surge 75% after depression drug reduces symptoms in late-stage study
Axsome shares surge 75% after depression drug reduces symptoms in late-stage study
Reuters: Health
Axsome Therapeutics Inc said on Monday its drug succeeded in reducing symptoms of major depressive disorder in a late-stage trial, taking the company a step closer to entering a multi-billion dollar market for depression treatments. 
Reuters: Health
Axsome Therapeutics Inc said on Monday its drug succeeded in reducing symptoms of major depressive disorder in a late-stage trial, taking the company a step closer to entering a multi-billion dollar market for depression treatments.
An oncologist’s take on refocusing the battle against cancer - In "The First Cell," Azra Raza argues that it’s far more effective to attack cancer in its earliest stages.
Asthma severity linked to microbiome of upper airway - A new study suggests there is a link between bacteria that live in the upper airway & the severity of asthma symptoms among children with mild to moderate asthma.
Gilead's NASH combination treatment fails main goal of mid-stage study
Gilead's NASH combination treatment fails main goal of mid-stage study
Reuters: Health
Gilead Sciences Inc said on Monday all combinations of its three drugs to treat non-alcoholic steatohepatitis (NASH)failed to meet the main goal of a mid-stage study, the latest in a string of failures to treat the fatty liver disease that has no approved treatment. 
Reuters: Health
Gilead Sciences Inc said on Monday all combinations of its three drugs to treat non-alcoholic steatohepatitis (NASH)failed to meet the main goal of a mid-stage study, the latest in a string of failures to treat the fatty liver disease that has no approved treatment.
Subscribe to:
Comments (Atom)